Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: Low-Molecular-Weight Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia

48 views
March 15, 2023
Comments 0
Login to view comments. Click here to Login